Russell Investments Group, Ltd. Biomarin Pharmaceutical Inc Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 45,522 shares of BMRN stock, worth $3.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,522
Previous 57,520 20.86%
Holding current value
$3.03 Million
Previous $4.74 Million 32.44%
% of portfolio
0.0%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$69.02 - $93.84 $828,101 - $1.13 Million
-11,998 Reduced 20.86%
45,522 $3.2 Million
Q2 2024

Aug 08, 2024
SELL
$74.43 - $92.22 $543,785 - $673,759
-7,306 Reduced 11.27%
57,520 $4.74 Million
Q1 2024

May 08, 2024
BUY
$83.81 - $99.0 $1.96 Million - $2.32 Million
23,414 Added 56.54%
64,826 $5.66 Million
Q4 2023

Feb 05, 2024
BUY
$76.22 - $98.51 $97,256 - $125,698
1,276 Added 3.18%
41,412 $3.99 Million
Q3 2023

Nov 13, 2023
SELL
$85.07 - $94.48 $7.35 Million - $8.17 Million
-86,429 Reduced 68.29%
40,136 $3.55 Million
Q2 2023

Aug 10, 2023
SELL
$86.68 - $100.3 $11 Million - $12.7 Million
-126,747 Reduced 50.04%
126,565 $11 Million
Q1 2023

May 09, 2023
SELL
$87.74 - $117.27 $3.75 Million - $5.02 Million
-42,790 Reduced 14.45%
253,312 $24.6 Million
Q4 2022

Feb 08, 2023
BUY
$80.93 - $108.63 $4.12 Million - $5.53 Million
50,879 Added 20.75%
296,102 $30.6 Million
Q3 2022

Nov 04, 2022
BUY
$82.16 - $96.94 $12.7 Million - $15 Million
154,900 Added 171.5%
245,223 $20.8 Million
Q2 2022

Jul 29, 2022
BUY
$71.48 - $86.85 $3.97 Million - $4.82 Million
55,505 Added 159.41%
90,323 $7.51 Million
Q1 2022

May 05, 2022
SELL
$74.28 - $92.69 $351,195 - $438,238
-4,728 Reduced 11.96%
34,818 $2.7 Million
Q4 2021

Jan 21, 2022
SELL
$71.72 - $91.47 $802,833 - $1.02 Million
-11,194 Reduced 22.06%
39,546 $3.51 Million
Q3 2021

Nov 08, 2021
BUY
$74.77 - $85.47 $996,833 - $1.14 Million
13,332 Added 35.64%
50,740 $3.91 Million
Q2 2021

Aug 04, 2021
BUY
$75.51 - $84.79 $570,478 - $640,588
7,555 Added 25.31%
37,408 $3.12 Million
Q1 2021

May 10, 2021
SELL
$74.73 - $90.69 $1.97 Million - $2.39 Million
-26,362 Reduced 46.89%
29,853 $2.25 Million
Q4 2020

Feb 08, 2021
SELL
$72.61 - $90.2 $169,399 - $210,436
-2,333 Reduced 3.98%
56,215 $4.92 Million
Q3 2020

Nov 09, 2020
SELL
$71.87 - $131.03 $1.34 Million - $2.44 Million
-18,630 Reduced 24.14%
58,548 $4.45 Million
Q2 2020

Aug 05, 2020
BUY
$79.55 - $124.22 $4.72 Million - $7.37 Million
59,355 Added 333.02%
77,178 $9.5 Million
Q1 2020

May 06, 2020
SELL
$71.37 - $96.85 $39,967 - $54,236
-560 Reduced 3.05%
17,823 $1.48 Million
Q3 2019

Nov 01, 2019
SELL
$67.4 - $85.11 $1.93 Million - $2.44 Million
-28,705 Reduced 60.96%
18,383 $1.25 Million
Q2 2019

Aug 09, 2019
BUY
$80.35 - $93.9 $709,088 - $828,667
8,825 Added 23.06%
47,088 $4.01 Million
Q1 2019

May 13, 2019
BUY
$84.2 - $98.62 $1.06 Million - $1.25 Million
12,628 Added 49.26%
38,263 $3.39 Million
Q4 2018

Feb 11, 2019
SELL
$80.14 - $106.07 $480,920 - $636,526
-6,001 Reduced 18.97%
25,635 $2.16 Million
Q3 2018

Oct 26, 2018
SELL
$93.92 - $105.72 $1.08 Million - $1.21 Million
-11,466 Reduced 26.6%
31,636 $3.08 Million
Q2 2018

Aug 08, 2018
BUY
$76.01 - $99.03 $808,290 - $1.05 Million
10,634 Added 32.75%
43,102 $4.03 Million
Q1 2018

May 11, 2018
SELL
$77.67 - $92.63 $5.85 Million - $6.98 Million
-75,362 Reduced 69.89%
32,468 $2.63 Million
Q4 2017

Feb 06, 2018
SELL
$80.76 - $95.13 $9.62 Million - $11.3 Million
-119,061 Reduced 52.47%
107,830 $9.76 Million
Q3 2017

Nov 07, 2017
BUY
$80.6 - $94.95 $18.3 Million - $21.5 Million
226,891
226,891 $21.1 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email